ArticleEuropean journal of neurology2025

Assessing Real World Efficacy, Safety, and 18-Month Retention Rates of Cannabidiol in Individuals With Drug Resistant Epilepsies.

Nicole Chemaly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.